An overview of Health Insurance Marketplace
01

An overview of Health Insurance Marketplace

The Healthcare.gov Marketplace, also known as the Health Insurance Marketplace or simply the Marketplace, is a vital element of the Affordable Care Act (ACA). The federal government established the Healthcare.gov Marketplace as a comprehensive online platform to help individuals and families find and purchase health insurance plans that comply with the ACA. It is basically a one-stop shop for comparing health insurance options, checking financial assistance eligibility, and enrolling in a plan meeting coverage needs. Open Enrollment Period The Healthcare.gov Marketplace operates on an annual enrollment schedule. The deadline typically starts from November 1st and is open till December 15 th . During this open enrollment period, eligible applicants can apply for health insurance, renew existing coverage, and even update coverage for existing plans if previously enrolled in the scheme. Where individuals miss complying with the OEP deadlines, a Special Enrollment Period (SEP) is applicable, where individuals can enroll and make changes. Most U.S. citizens and legal residents are eligible to use the Healthcare.gov Marketplace to find health insurance coverage. These are the qualifying criteria to avail the federal benefit: Applicant must reside in the United States. Applicants cannot be incarcerated. Eligible applicants should not have existing coverage through a job-based plan that meets certain minimum standards of affordability and coverage.
Read More
7 overlapping symptoms of Parkinson’s and TD
02

7 overlapping symptoms of Parkinson’s and TD

Parkinson’s disease (PD) and tardive dyskinesia (TD) are neurological conditions affecting motor functions. While they have distinct etiologies and symptoms, at times, there are surprising similarities in their effects. It is important to understand the commonalities between these two conditions, as the evaluation of their early signs may lead to misdiagnosis. Recognizing the symptoms can help one get an accurate diagnosis and appropriate treatment. So, here are a few overlapping signs of both disorders: Involuntary movements Involuntary movements are a shared sign of both Parkinson’s disease and tardive dyskinesia, albeit with distinct characteristics. With Parkinson’s, involuntary movements typically manifest as resting tremors, which are rhythmic, quivering motions developing when one is at rest. These tremors often involve the hands, fingers, and occasionally the jaw or lips. Additionally, with PD, one may experience bradykinesia, which is slowness of movement and rigidity, where the muscles become stiff and inflexible. These symptoms collectively result in a reduced ability to initiate and control movements. In contrast, TD causes involuntary, repetitive movements usually involving the facial muscles. These movements include lip smacking, tongue protrusion, and grimacing. However, TD might also affect the limbs and trunk, causing abnormal writhing motions. Unlike PD tremors, TD movements are often more conspicuous and disruptive, impacting facial expressions and speech.
Read More
Here’s what makes Novavax an alternative to mRNA vaccines
04

Here’s what makes Novavax an alternative to mRNA vaccines

When it comes to vaccine development, two innovative approaches have taken center stage in recent years—protein subunit (Novavax) and mRNA vaccines. Both are methods of bolstering immunity against infectious diseases, each with its own set of merits and considerations. To highlight the difference between both approaches, this article explores the characteristics of COVID-19 vaccines, highlighting what makes Novavax an alternative to mRNA vaccines in helping build immunity against the disease: Disease-specific considerations The nature of the infectious disease in question plays a pivotal role in determining which vaccine approach is most appropriate. In situations where rapid response is essential, such as the early stages of a pandemic, mRNA vaccines, with their shorter development timelines, may offer a distinct advantage. Here, the ability to swiftly generate and distribute these vaccines was evident in the last few years. On the other hand, for a targeted adaptation to emerging variants, Novavax’s adaptable protein subunit technology can be utilized. Here, the capability to accommodate evolving viral strains makes the vaccine part of the long-term vaccination strategy. Vaccine technology To understand the differences and similarities between Novavax and mRNA vaccines, here are the fundamental principles underlying these vaccine technologies. – The mRNA vaccines work by introducing a small piece of genetic material, called messenger RNA (mRNA), into the body.
Read More